A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism
Identifieur interne : 003A49 ( Istex/Checkpoint ); précédent : 003A48; suivant : 003A50A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism
Auteurs : A. Negrotti [Italie] ; Calzetti [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 1997-01.
English descriptors
- KwdEn :
Abstract
The natural course of calcium‐entry blocker–induced parkinsonism was evaluated in 13 elderly patients previously exposed to cinnarizine or flunarizine or both for a median period of 7 months. Clinical assessments were carried out before drug discontinuation and twice thereafter over a period lasting ≤7 years. None of the patients showed a full recovery of extrapyramidal signs, indicating that the long‐term prognosis of the parkinsonism is less benign than previously reported. Two main patterns of clinical outcome were recognized (i.e., “remittent” and “persistent and not progressive”parkinsonism), whereas the development of a progressive disorder was observed only in one patient. No significant correlation was found between the patterns of outcome and some clinical variables, such as total duration of exposure to cinnarizine and flunarizine, cumulative drug dosages, and age at onset of parkinsonism. There was no significant difference in terms of family history of essential tremor or parkinsonism or both among the patients with the two main patterns of clinical course.
Url:
DOI: 10.1002/mds.870120119
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:B76868CF03D01070A891C66A47A9A4CDFAF31704Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism</title><author><name sortKey="Negrotti, A" sort="Negrotti, A" uniqKey="Negrotti A" first="A." last="Negrotti">A. Negrotti</name></author><author><name sortKey="Calzetti" sort="Calzetti" uniqKey="Calzetti" last="Calzetti">Calzetti</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B76868CF03D01070A891C66A47A9A4CDFAF31704</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1002/mds.870120119</idno><idno type="url">https://api.istex.fr/document/B76868CF03D01070A891C66A47A9A4CDFAF31704/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002D67</idno><idno type="wicri:Area/Istex/Curation">002D67</idno><idno type="wicri:Area/Istex/Checkpoint">003A49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism</title><author><name sortKey="Negrotti, A" sort="Negrotti, A" uniqKey="Negrotti A" first="A." last="Negrotti">A. Negrotti</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Neurologia, Università di Parma, Parma</wicri:regionArea><wicri:noRegion>Parma</wicri:noRegion></affiliation></author><author><name sortKey="Calzetti" sort="Calzetti" uniqKey="Calzetti" last="Calzetti">Calzetti</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Neurologia, Università di Parma, Parma</wicri:regionArea><wicri:noRegion>Parma</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="1997-01">1997-01</date><biblScope unit="vol">12</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="107">107</biblScope><biblScope unit="page" to="110">110</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">B76868CF03D01070A891C66A47A9A4CDFAF31704</idno><idno type="DOI">10.1002/mds.870120119</idno><idno type="ArticleID">MDS870120119</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cinnarizine</term><term>Drug‐induced</term><term>Flunarizine</term><term>Long‐term outcome</term><term>Parkinsonism</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The natural course of calcium‐entry blocker–induced parkinsonism was evaluated in 13 elderly patients previously exposed to cinnarizine or flunarizine or both for a median period of 7 months. Clinical assessments were carried out before drug discontinuation and twice thereafter over a period lasting ≤7 years. None of the patients showed a full recovery of extrapyramidal signs, indicating that the long‐term prognosis of the parkinsonism is less benign than previously reported. Two main patterns of clinical outcome were recognized (i.e., “remittent” and “persistent and not progressive”parkinsonism), whereas the development of a progressive disorder was observed only in one patient. No significant correlation was found between the patterns of outcome and some clinical variables, such as total duration of exposure to cinnarizine and flunarizine, cumulative drug dosages, and age at onset of parkinsonism. There was no significant difference in terms of family history of essential tremor or parkinsonism or both among the patients with the two main patterns of clinical course.</div></front></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Negrotti, A" sort="Negrotti, A" uniqKey="Negrotti A" first="A." last="Negrotti">A. Negrotti</name></noRegion><name sortKey="Calzetti" sort="Calzetti" uniqKey="Calzetti" last="Calzetti">Calzetti</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 003A49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:B76868CF03D01070A891C66A47A9A4CDFAF31704
|texte= A long‐term follow‐up study of cinnarizine‐ and flunarizine‐induced parkinsonism
}}
| This area was generated with Dilib version V0.6.23. |  |